Print    Email
Decrease (-) Restore Default Increase (+)
Bookmark and Share

Procedures

3D Conformal Radiation Therapy (3DCRT)
In the past, radiation oncologists could only plan using two dimensions (width and length), due to limitations in imaging technology. With current advanced imaging and computer technology, CRTC's Radiation Oncologists can plan treatment in three dimensions (length, width, and depth). This process is known as 3D Conformal Radiation Therapy (3DCRT).

The process starts with a CT scan, which gives a three dimensional picture of the patient's body, including the tumor to be treated as well as all normal anatomy. This picture can be supplemented with additional information from other 3D images such as PET and MRI scans which can be "fused" or superimposed with the planning CT. 

Using this picture as a map of the body, the Radiation Oncologist identifies the target to be treated and any sensitive healthy tissue that needs to be avoided. The Radiation Oncology team then uses powerful computers to design a radiation treatment plan with multiple beams aimed at the target. Each beam is shaped to deliver the optimal dose to the target, while avoiding surrounding sensitive normal structures. Thus, the radiation "conforms" to the target volume.

Intensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) is a specialized form of 3DCRT that allows radiation to be more precisely shaped to fit the tumor. With IMRT, the radiation beam can be broken up into many "beamlets" and the intensity of each beamlet can be adjusted individually. This allows for better control over shaping the radiation delivery to the target volume while avoiding healthy tissue. In many situations, this can allow a higher dose to the tumor while improving normal tissue avoidance, increasing chance for cure.

Image Guided Radiation Therapy (IGRT)
3D-CRT/IMRT is further enhanced with use of daily image guidance (IGRT). One challenge that the radiation oncology team faces is how to accurately and consistently position the patient for their daily treatments. Tumors are not always where they are expected to be because of patient movement/breathing and normal tissue filling (GI tract, rectum, bladder, etc.) which can change between each treatment and during treatment.
With IGRT an image is obtained daily before and during radiation treatments. This identifies precisely where the tumor and other critical normal structures reside at the most important time, when the treatment is being given. In some cases, we implant a tiny piece of metal called a fiducial marker near or in the tumor to further help localize the tumor during IGRT.  Changes in set up can be made to insure optimal daily targeting.
CRTC offers the most advanced Image Guided Radiation Therapy currently available. We utilize daily infra-red visualization and kilovoltage-based tumor tracking using BrainLab's Exac-Trac 6-dimensional X-ray system. This allows day-to-day accuracy to within one to two millimeters, a level of precision that is higher than what has ever been achieved before.

4D (four-dimension) CT-based treatment planning
A technique that provides information to help plan when breathing impacts tumor motion. This allows us to conform the radiation dose to the tumor's motion. By accounting for tumor motion during breathing, doses to critical normal organs can be limited allowing the delivery of higher doses to the tumor. This tool along with other technologies allows Stereotactic Body Radiation Therapy (discussed later below).

Brain Stereotactic Radiosurgery (SRS)
Stereotactic Radiosurgery is a highly precise form of radiation therapy used primarily to treat tumors and other abnormalities of the brain. This has been performed by CRTC Radiation Oncologists for more than ten years, which is longer than any other department in the state. Despite its name, stereotactic radiosurgery is a non-surgical procedure that delivers a single high dose of precisely targeted radiation using highly focused
X-ray beams aimed at the brain tumor. This is usually provided in a single treatment however is sometimes provided in multiple sessions for larger tumors.  SRS requires a collaborative effort between the Neurosurgeon, Radiation Oncologist, and Medical Physicist. When being treated with such high doses in a single or very few sessions, patient immobilization becomes much more important. For that reason a head frame (halo) is often placed by the Neurosurgeon. Newer devices also allow for less invasive frame-less based immobilization.

Stereotactic Radiosurgery  (SRS) for the brain has been around for more than 40 years by the Gamma Knife system. Newer tools for Stereotactic Brain Radiosurgery involve LINAC based systems where a Linear Accelerator is used to deliver x-rays by way of a gantry that rotates around the patient to deliver the radiation from different angles (Gamma Knife delivers multiple beams while being stationary). The LINAC based system has a technical advantage over Gamma Knife in circumstances where the tumor is relatively large, being able to deliver a more uniform dose. CRTC utilizes such LINAC based stereotactic systems to provide SRS. The Brain Radiosurgery suite has also been updated with the latest technology. We currently use the Radionics X-knife system for SRS.

Stereotactic Radiosurgery (SRS) is an important alternative to invasive surgery, especially for tumors located deep within or close to vital areas of the brain or for patients not able to tolerate traditional neurosurgery.

Stereotactic Body Radiation Therapy (SBRT)
Stereotactic Body Radiation Therapy (SBRT) is a similar procedure to stereotactic radiosurgery for the brain, except it is used on tumors within the body. This is provided in 5 treatments or less (as opposed to traditional radiation which may take several weeks).  SBRT is most commonly used for small tumors within the lung, liver, and spine.

SBRT is a relatively recent advancement as opposed to SRS.  In the past, the ability to direct such a localized ablative form of radiation to the body was limited by previous imaging techniques, lack of optimal daily patient/tumor set-up verification, and the fact that tumors within the body move.  Tumors move on a daily basis dependent on normal organ filling, emptying (GI tract, bladder) and during breathing (diaphragm).  Recent advancements in imaging techniques (see 4D-CT planning above), immobilization tools (vacloc, body frames, etc.), and precise daily patient/tumor positioning verification (see IGRT above) have allowed radiation oncologists to provide SBRT.

With SBRT, local control for small tumors in many cases is as good as with surgery or better than invasive procedures.  It is often utilized in circumstances where surgery is not an option.  With better target localization via image guided planning and delivery, and patient immobilization, more healthy tissue near the tumor is unharmed with SBRT.

CRTC Radiation Oncologists have been providing SBRT for more than two years.

Names for Stereotactic Radiation
There is often confusion regarding the brand naming for equipment separate from the terminology of SRS or SBRT. Stereotactic radiation may be delivered by a number of different devices. Brand name stereotactic treatment machines/systems include: Axesse, BrainLab's ExacTrac, CyberKnife, Elekta, Gamma Knife, Novalis, Primatom, Radionic's X-Knife, Sieman's MVision, Synergy, Tomo Therapy, Trilogy, Varian, etc. 
It is important not to confuse these brand names with the actual type of stereotactic radiation under consideration. There are some technical advantages/disadvantages between the various systems, however, there has been no significant clinical advantage demonstrated between the various brand names. What is clinically significant is that the appropriate case be chosen for SRS or SBRT (stereotactic radiation) and that the optimal radiation dose/volume and fractionation (# of treatments) is provided. This will be determined by the Radiation Oncologist.

The CRTC radiation oncology practice currently has three such brand name machines/systems for delivering SRS or SBRT namely, Radionic's X-Knife, Sieman's MVision, and BrainLab's ExacTrac. CRTC and CAMC are also committed to staying ahead of the technology curve through obtaining and appropriately utilizing the latest in state-of-the-art technology to better fight cancer.

Superficial Radiation Therapy (Skin Treatment)
Radiation therapy is an extremely effective method for treating (non-melanoma) skin cancer. Non-melanoma skin cancer includes basal cell and squamous cell skin cancers. Superficial (on the skin) treatment for such skin cancers can be provided by a special machine that has a better ability to treat the skin while avoiding and preserving underlying tissues. Superficial treatment machines are not commonly found at most radiation oncology practices, however, CRTC houses just such a machine, namely, the Picker superficial x-ray unit. Radiation treatment for skin cancer (non-melanoma) has excellent control rates and cosmetic outcome. Such treatment allows many patients to avoid the alternative option of surgery, which can often result in scarring/cosmetic changes.

High Dose Rate Brachytherapy (HDR)
High Dose Rate Brachytherapy (HDR), also referred to, as "internal radiation therapy" is a radiation treatment, which uses a small radioactive source temporarily, placed inside or near the tumor. Interstitial HDR Brachytherapy is performed for Soft tissue sarcomas as an adjunct to surgery. Intracavitary HDR Brachytherapy is provided as a definitive treatment (along with external beam radiation) for advanced uterine cervix cancer and as an adjunct (alone) following hysterectomy for higher risk uterine endometrial cancer (vaginal cuff).

Under computer control the position and timing of the radiation source placement can be precisely controlled, allowing the physician to shape the radiation dose to the target. Because of the high dose rate characteristics, this brachytherapy treatment is provided during a short time frame on an outpatient basis. This avoids the hospitalization (and related complications with extended patient immobilization) that was required with previous low dose rate techniques (LDR).

Mammosite Brachytherapy (Accelerated Partial Breast Treatment)
CRTC radiation oncologists and Charleston surgeons offer Mammosite Brachytherapy as a treatment option for selected early stage breast cancer in conjunction with a lumpectomy. This treatment option uses an Iridium-192 radioactive source, which delivers radiation to the lumpectomy cavity (partial breast) by way of a Mammosite balloon. At the time of the lumpectomy or shortly after, the surgeon will place the deflated mammosite balloon into the cavity, which is inflated by catheter conforming to the lumpectomy cavity prior to the radiation delivery. This radiation treatment is delivered two times a day for five days as opposed to standard fractionated treatment, which is delivered daily for five to six weeks.

Prostate Seed Brachytherapy
With this technique, radiation can be delivered to the prostate alone by implanting radioactive seeds (permanent seed implants using Iodine-125 or Palladium-103). For high risk category prostate cancer the seed brachytherapy should be combined with a shortened course of external beam radiation therapy (5 weeks). For low risk category prostate cancer the seed brachytherapy is provided alone. The major advantage for seed implant is the ability to give a high radiation dose while confining the treatment more tightly to the prostate, which leads to excellent tumor control and fewer long-term complications. Prostate brachytherapy is a combined effort where CRTC radiation oncologists perform this procedure along with CAMC urologists. The Prostate Brachytherapy program has been refined at CAMC for nearly 10 years representing one of the strongest experiences in the state (over 300 cases performed).

The recommendation for prostate seed brachytherapy (implants) depends on a number of patient and tumor factors: this includes pre-treatment prostate size, urinary symptoms, previous prostate surgical history (TURP), cancer risk profile (low vs. intermediate vs. high risk category), and the patient's surgical candidacy and desires. Depending on these factors many patients may better be served by treating the prostate with modern external beam radiation therapy (see IMRT/IGRT above) or prostatectomy (also see daVinci Robotic surgery discussed elsewhere in this book). The breadth of treatment options available allows the physician and patient to select the specific treatment, which is best suited to each patient's particular medical needs.
CRTC radiation oncologists strongly favor a multidisciplinary approach for making decisions regarding optimal treatment for prostate cancer and encourage patients to seek consultations with a urologic surgeon as well as a radiation oncologist. CAMC radiation oncologists, urologists, and medical oncologists meet regularly during "peer review conference" where we collectively review and discuss optimal treatment options for urologic cancer cases.

Pediatric Radiation Therapy
CRTC radiation oncologists have experience treating common and very rare forms of childhood cancers at CAMC. Radiation treatment is often an integral part of optimal treatment for cancers in the pediatric population. Depending on each child's specific diagnosis, radiation therapy may be used as the primary form of treatment, or may be used before or after other types of treatment such as surgery or chemotherapy. CRTC and CAMC are also on the leading edge in offering state-of-the-art radiation therapy options for childhood cancer. The pediatric radiation therapy program builds upon CAMC's well established and experienced Pediatric Oncology department. Along with CAMC pediatric oncologists and their staff, CRTC radiation oncologists, medical physicists, and other scientists actively participate in research through the national Children's Oncology Group (COG).

Radiation Oncology Research and Education
CRTC and CAMC are dedicated to providing patients with the most up-to-date radiation treatment options. CRTC and CAMC are affiliated with the internationally renowned Radiation Therapy Oncology Group (RTOG) and offer enrollment in RTOG clinical trials for qualifying patients. Through this affiliation, multiple clinical trials for patients with higher risk prostate cancer have recently been made available for enrollment.
The radiation oncologists also participate as Assistant Clinical Professors for the WVU School of Medicine and offer elective educational rotations for medical students as well as for CAMC training Resident doctors interested in oncology. The multidisciplinary approach to cancer care coupled with the use of cutting edge technologies and dedication to research and education help provide better outcomes and experiences for patients.

Radiation Physics
One of the primary interests in radiation physics is to make improvements upon existing radiation treatment planning techniques. These efforts ensure the highest quality and standard in radiation treatment planning at CAMC.

Our Mission: Striving to provide the best health care to every patient, every day.       © 2014 CAMC Health System, Inc.